NPPES file of Aug 9, 2026

Rahul Ramesh Naik, M.D.

Hematology & Oncology Physician · Los Angeles, CA

Rahul Ramesh Naik, M.D. is a hematology & oncology physician with a practice address in Los Angeles, California, and NPI 1992999031, issued on Aug 31, 2007. Check the license (California A101362, as entered in NPPES) on the Medical Board of California; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1992999031
Name
Rahul Ramesh Naik
Credential
M.D.
Primary taxonomy
Hematology & Oncology Physician 207RH0003X
License number
A101362 CA
Self-reported in NPPES; status is on the state search
Practice location
1700 E. Cesar Chavez Ave, Los Angeles, CA 90033
Phone
(323) 264-0430
Enumerated
Aug 31, 2007
Record last updated
Aug 24, 2021 (not updated in 5 years: call before relying on the address or phone)
Fax
(323) 264-2354
Medicare enrollment
Enrolled (PECOS I20120910000741); accepts Medicare assignment
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 1700 E. Cesar Chavez Ave

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Bryan Johnson, PA-CPhysician Assistant1316438807

Verify Rahul Ramesh Naik in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersMedical Board of California
    Search for license A101362
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the California license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

5.3 times the Medicare Part D claims of the average hematology & oncology physician in 2024

4,658 Medicare Part D claims for 691 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 40% of claims. 301 claims were for opioids.

  1. Rahul Naik4,658
  2. Specialty average877

Most prescribed

  1. Anastrozole531 claims
  2. Ondansetron Hcl229 claims
  3. Prochlorperazine Maleate195 claims
  4. Orgovyx188 claims
  5. Hydrocodone-Acetaminophen177 claims
  6. Letrozole172 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Industry payments in 2024: $36,217.13

186 payments; by number, the most common kind was food and beverage; the largest payer was Karyopharm Therapeutics Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Rahul Naik$36,217
  2. Specialty average$7,481

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Austin J MA MD A Professional CorporationPasadena, CA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Hematology & Oncology Physician providers in California

There are 1,583 hematology & oncology physician records in California.

Other hematology & oncology physician records in California

  1. Mark Abate, M.D.Santa Barbara, CA1588778674
  2. Iman Abdalla, MDLos Angeles, CA1730248311
  3. Haifaa Abdulhaq, MDFresno, CA1508024647
  4. Nihal Abdulla, MDLos Alamitos, CA1750585345
  5. Mehrad Abedi, M.D.Sacramento, CA1467459222
  6. Oyewale Abidoye, M.D.La Jolla, CA1790841815
  7. Mohammed Abu Zaanona, MDSanta Barbara, CA1922591197
  8. Mohamad Adada, M.D., PHDRoseville, CA1528590734
  9. Jesse Adams, MDSacramento, CA1851479554
  10. Thompson Adams, MDSanta Monica, CA1407880891

Common questions

What is Rahul Ramesh Naik, M.D.'s NPI number?

Rahul Ramesh Naik, M.D.'s National Provider Identifier (NPI) is 1992999031, issued on Aug 31, 2007. An NPI identifies a provider in billing; it is not a license.

Where is Rahul Ramesh Naik, M.D. located?

The NPPES record lists a practice address at 1700 E. Cesar Chavez Ave, Los Angeles, CA, 90033. Phone: (323) 264-0430. Providers update this record themselves, so call before visiting.

How can I verify Rahul Ramesh Naik, M.D.'s license?

NPPES lists California license number A101362, as entered by the provider. Search the Medical Board of California at https://www.mbc.ca.gov/License-Verification/default.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Rahul Ramesh Naik, M.D. prescribe under Medicare Part D?

In 2024, Rahul Ramesh Naik, M.D. had 4,658 Medicare Part D claims for 691 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.